Hemorrhagic-ischemic cerebral injury in the preterm infant: Current concepts

Clinics in Perinatology

Volumn 29, Issue 4, 2002, Pages 745-763

  Shalak, Lina ^a   Perlman, Jeffrey M ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CYTOKINE; ETAMSYLATE; EXCITOTOXIN; FREE RADICAL; GLUCOCORTICOID; GLUTAMIC ACID; INDOMETACIN; PHENOBARBITAL; VITAMIN K GROUP;

BRAIN BLOOD FLOW; BRAIN DEVELOPMENT; BRAIN HEMORRHAGE; BRAIN INJURY; BRAIN ISCHEMIA; CLINICAL FEATURE; ECHOGRAPHY; ENCEPHALOMALACIA; HUMAN; NEUROPATHOLOGY; PATHOGENESIS; PREMATURITY; PRIORITY JOURNAL; REVIEW; VERY LOW BIRTH WEIGHT; WHITE MATTER;

BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; CEREBRAL VENTRICLES; CYTOKINES; DEVELOPMENTAL DISABILITIES; FREE RADICALS; HUMANS; INFANT MORTALITY; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; INFLAMMATION; LEUKOMALACIA, PERIVENTRICULAR; POSTNATAL CARE; PREDICTIVE VALUE OF TESTS; PRENATAL CARE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0036945427     PISSN: 00955108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0095-5108(02)00048-9     Document Type: Review

References (134)

1. Perlman JM, Rollins N, Burns, D, et al. Relationship between periventricular intraparenchymal echodensities and germinal matrix-intraventricular hemorrhage in the very low birth weight neonate. Pediatrics 1993;91:474-80.
2. Volpe JJ. Neurology of the Newborn. 4th Edition. Philadelphia: WB Saunders; 2001.
3. Lemons JA, Bauer CR, Oh W, et al. Very low birth weight outcomes of the National Institute of Child Health and Human Development, Neonatal Research Network, January 1995 through December 1996. Pediatrics 2001;107.
4. Philips AGS, Allen WC, Tito AM, et al. Intraventricular hemorrhage in preterm infants: Declining incidence in the 1980's. Pediatrics 1989;84:797-800.
5. Hambleton G, Wiggelsworth JS. Origin of intraventricular hemorrhage in the preterm infant. Arch Dis Child 1976;57:651-5.
6. Perlman JM, Rollins N. Surveillance protocol for the detection of intracranial abnormalities in premature neonates. Arch Pediatr Adolesc Med 2000; 154:822-6.
7. Gould SJ, Howard S, Hope PL, et al. Periventricular intraparenchymal cerebral hemorrhage in preterm infants: The role of venous infarction. J Pathol 1987;151:197-202.
8. Guzzetta F, Schackelford GD, Volpe S, et al. Periventricular intraparenchymal echodensities in the premature newborn: Critical determinant of neurologic outcome. Pediatrics 1986;78: 945-1006.
9. Goddard-Finegold J, Armstrong D, Zeller RS. Intraventricular hemorrhage following volume expansion after hypovolemic hypotension in the newborn beagle. J Pediatr 1982;100: 796-9.
10. Ment LR, Stewart WB, Duncan CC, et al. Beagle puppy model of intraventricular hemorrhage. J Neurosurg 1982;57:219-23.
11. Lou CH, Lassen NA, Friis-Hansen B. Impaired autoregulation of cerebral blood flow in the distressed newborn infant. J Pediatr 1979;94:118-25.
12. Pryds O, Griesen G, Lou H, et al. Heterogeneity of cerebral vasoreactivity in preterm infants supported by mechanical ventilation. J Pediatr 1989;115:638-45.
13. Goldberg RN, Chung D, Goldman SL, et al. The associations of rapid volume expansion and intraventricular hemorrhage in the preterm infant. J Pediatr 1980;96:1060-3.
14. Hill A, Perlman JM, Volpe JJ. Relationship of pneumothorax to the occurrence of intraventricular hemorrhage in the premature newborn. Pediatrics 1982;69:144-9.
15. Perlman JM, McMenamin JB, Volpe JJ. Fluctuating cerebral blood flow velocity in respiratory distress syndrome. Relation to the development of intraventricular hemorrhage. N Engl J Med 1983;309:204-9.
16. Tsuji M, Saul JP, du Plessis A, et al. Cerebral intravascular oxygenation correlates with mean arterial pressure in critically ill premature infants. Pediatrics 2000;106:625-32.
17. Bada HS, Korones SB, Perry EH, et al. Mean arterial blood pressure changes in premature infants and those at risk for intraventricular hemorrhage. J Pediatr 1990;117:607-14.
18. Miall-Allen VM, De Vries LS, Whitelaw AG. Mean arterial blood pressure and neonatal cerebral lesions. Arch Dis Child 1987;62:1068-9.
19. Perlman JM, Volpe JJ. Are venous circulatory changes important in the pathogenesis of hemorrhagic and/or ischemic cerebral injury? Pediatrics 1987;80:705-11.
20. Vert P, Monin P, Sibout M. Intracranial venous pressure in newborns: Variations in physiologic and neurologic disorders. In: Stem L, Friis-Hansen B, Kildeberg P, editors. Intensive Care of Newborns. New York: Masson; 1975. p. 185.
21. Takashima S, Tanaka K. Microangiography and fibriolytic activity in the matrix of the premature brain. Brain Dev 1972;4:222-8.
22. Perlman JM, Nissen PD. Glial fibrillary acidic protein in RNA gene expression in human astroglial cells is modulated by dexamethasone [abstract]. Ann Neurol 1995;38:495.
23. Perlman JM, Risser R. Relationship of uric acid concentrations and severe intraventricular hemorrhage/leukomalacia in the premature infant. J Pediatr 1998;132:436-9.
24. Russell GAB, Jeffers G, Cook RWI. Plasma hypoxanthine: A marker for hypoxic-ischemic induced periventricular leukomalacia? Arch Dis Child 1992;67:388-92.
25. Allen WC, Vohr B, Makuch RW. Antecedents of cerebral palsy in a multicenter trial of indomethacin for intraventricular hemorrhage. Arch Pediatr Adolesc Med 1997;151:581-5.
26. Schmidt B, Davis P, et al. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N Engl J Med 2001;344:1966-72.
27. Perlman JM, Volpe JJ. Intraventricular hemorrhage in the extremely small premature infant. Am J Dis Child 1986;140:1122-4.
28. Kazzi N, Llagan NB, Liang KC, et al. Maternal administration of vitamin K does not improve the coagulation profile of preterm infants. Pediatrics 1989;84:1045-50.
29. Pomerance JJ, Teal JG, Gogolok JF, et al. Maternally administered antenatal vitamin K: Effect on neonatal prothrombin activity, partial prothrombin time and intraventricular hemorrhage. Obstet Gynecol 1987;70:235-41.
30. Shankaran S, Papile LA, Wright LL, et al. The effect of antenatal phenobarbital therapy on neonatal intracranial hemorrhage in preterm infants. N Engl J Med 1997;337:466-71.
31. Crowley P, Chalmers I, Keirse MJNC. The effects of corticosteroid administration before pre-term delivery: An overview of the evidence from clinical trials. Br J Obstet Gynecol 1990;97: 11-25.
32. Garite TJ, Rumney PJ, Briggs GC, et al. A randomized placebo controlled trial of betamethasone for the prevention of respiratory distress syndrome at 24-28 weeks gestation. Am J Obstet Gynecol 1992;166:646-51.
33. Jobe AH, Mitchell BR, Gunkel JH. Beneficial effects of combined use of prenatal steroids and postnatal surfactant on preterm infants. Am J Obstet Gynecol 1993;168:508-13.
34. Kari MA, Hallman M, Gronen M, et al. Prenatal dexamethasone treatment in conjunction with rescue therapy of human surfactant: A randomized placebo-controlled multicenter study. Pediatrics 1994;93:730-6.
35. Leviton A, Dammann O, Allred EN, et al. Antenatal corticosteroids and cranial ultrasonographic abnormalities. Am J Obstet Gynecol 1999;181:1007-17.
36. Maher JE, Cliver SP, Goldenberg RL, et al. March of Dimes Multicenter Study Group. The effect of glucocorticoid therapy in the very premature infant. Am J Obstet Gynecol 1994;170: 869-73.
37. Shankaran S, Bauer CR, Bain R, et al. Prenatal and perinatal risk and protective factors for neonatal intracranial hemorrhage. Arch Pediatr Adoles Med 1996;150:491-7.
38. Wright LL, Homar JD, Gunkel H. Evidence from multicenter networks on the current use and effectiveness of antenatal corticosteroids in low birthweight infants. Am J Obstet Gynecol 1995;173:263-9.
39. Demarini S, Dollberg S, Hoath SB, et al. Effects of antenatal corticosteroids on blood pressure in very low birth weight infants during the first 24 hours of life. J Perinatol 1999;19:419-25.
40. Garland JS, Buck R, Leviton A. Effect of maternal glucocorticoid exposure on risk of severe intraventricular hemorrhage in surfactant-treated preterm infants. J Pediatr 1995; 126:272-9.
41. Perlman JM, Risser RC, Gee JB. Pregnancy induced hypertension and reduced intraventricular hemorrhage in preterm infants. Pediatr Neurol 1997;17:29-33.
42. Kuban KCK, Leviton A, Pagano M, et al. Maternal toxemia is associated with a reduced incidence of germinal matrix hemorrhage in premature babies. J Child Neurol 1992;7:70-6.
43. Leviton A, Pagano M, Kuban KCK, et al. The epidemiology of germinal matrix hemorrhage during the first half of life. Dev Med Child Neurol 1988;33:138-45.
44. Gould JB, Gluck L, Kulovich MV. The relationship between accelerated pulmonary maturity and accelerated neurologic maturity in certain chronically stressed pregnancies. Am J Obstet Gynecol 1997;127:181-6.
45. Hadi HA. Fetal cerebral maturation in hypertension disorder in pregnancy. Obstet Gynecol 1984;63:214-9.
46. Nelson KB, Grether JK. Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants? Pediatrics 1995;95:263-9.
47. Leviton A, Paneth N, Susser MW, et al. Magnesium receipt does not appear to reduce the risk of neonatal white matter damage. Pediatrics 1997;99:E2.
48. Paneth N, Jettan J, Pinto-Martron J, et al. Magnesium sulfate and risk of neonatal brain lesions and cerebral palsy in low birthweight infants. Pediatrics 1997;99:1-7.
49. Atkinson MW, Goldenberg RL, Gaudier FL, et al. Maternal corticosteroid and tocolytic treatment and morbidity and mortality in very low birthweight infants. Am J Obstet Gynecol 1995;173:299-304.
50. Groome LJ, Goldenberg RL, Cliver SP, et al. March of Dimes Multicenter Study Group: Neonatal periventricular-intraventricular hemorrhage after maternal 3-sympathomimetic tocolysis. Am J Obstet Gynecol 1992;167:873-9.
51. Anderson GD, Bada HS, Shaver BM, et al. The effect of Cesarean section on intraventricular hemorrhage in the premature infant. Am J Obstet Gynecol 1992;166:1091-101.
52. Low JA, Galbraith RS, Sauerbrei EE, et al. Maternal fetal and newborn complications associated with newborn intracranial hemorrhage. Am J Obstet Gynecol 1986;154:345-52.
53. Strauss A, Kirz D, Mandalou HD, et al. Perinatal events and intraventricular/ependymal hemorrhage in the very low birthweight infant. Am J Obstet Gynecol 1985;151:1022-7.
54. Ment LR, Oh W, Ehrenkrantz R, et al. Antenatal steroids, delivery mode and intraventricular hemorrhage in preterm infants. Am J Obstet Gynecol 1995;172:795-800.
55. Hansen A, Leviton A. Labor and delivery characteristics and risks of cranial ultrasonographic abnormalities among very-low-birth-weight infants. The Developmental Epidemiology Network Investigators. Am J Obstet Gynecol 1999;181:997-1006.
56. Baud O, Foix-L'Helias L, Kaminsky M, et al. Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants. N Engl J Med 1999;341:1190-6.
57. Perlman JM. White matter injury in the preterm infant: An important determinant of abnormal neurodevelopmental outcome. Early Human Dev 1998;53:99-120.
58. Perlman JM. Intraventricular hemorrhage. Pediatrics 1989;84:913-4.
59. Perlman JM, Thach BT. Respiratory origin of fluctuations in arterial blood pressure in premature infants with respiratory distress syndrome. Pediatrics 1988;81:399-403.
60. Perlman JM, Goodman S, Kreusser KL, et al. Reduction of intraventricular hemorrhage by elimination of fluctuating cerebral blood flow velocity in preterm infants with respiratory distress syndrome. N Engl J Med 1985;312:1253-7.
61. Jobe AH. Pulmonary surfactant therapy. N Engl J Med 1993;328:861-8.
62. Bedard MP, Shankaran S, Slovis TL, et al. Effect of prophylactic phenobarbital on intraventricular hemorrhage in high risk infants. Pediatrics 1984;73:435-9.
63. Donn S, Roloff DW, Goldstein GW. Prevention of intraventricular hemorrhage in preterm infants by phenobarbitone: A controlled trial. Lancet 1981;ii:215-7.
64. Kuban KC, Leviton A, Krishnamoorthy KS, et al. Neonatal intracranial hemorrhage and phenobarbital. Pediatrics 1986;77:443-50.
65. Sinha S, Davis J, Tonger N, et al. Vitamin E supplementation reduces frequency of periventricular hemorrhage in very preterm infants. Lancet 1987;ii:466-71.
66. Morgan ME, Benson JT, Cooke RW. Ethamsylate reduces the incidence of periventricular haemorrhage in very low birthweight babies. Lancet 1981;i:830-1.
67. Bada HS, Green RS, Pourcyrous M, et al. Indomethacin reduces the risk of severe intraventricular hemorrhage. J Pediatr 1990;115:631-7.
68. Ment LR, Oh W, Ehrenkranz RA, et al. Low-dose indomethacin and prevention of intraventricular hemorrhage: A multicenter randomized trial. Pediatrics 1994;94:543-50.
69. Edwards AD, Wyatt JS, Richardson C, et al. Effects of indomethacin on cerebral hemodynamics in very preterm infants. Lancet 1990;335:491-5.
70. Pryds O, Griesen G, Johansen KH. Indomethacin and cerebral blood flow in preterm infants treated for patent ductus arterious. J Pediatr 1988;147:315-6.
71. Stewart AL, Reynolds EOR, Hope RL, et al. Probability of neurodevelopmental disorders estimated from ultrasound appearance of brains of very preterm infants. Dev Med Child Neurol 1987;29:3-11.
72. Leviton A, Paneth N. White matter damage in preterm newborns - An epidemiologic perspective. Early Hum Dev 1990;24:1-22.
73. De Vries LS, Regev R, Dubowitz LMS, et al. Perinatal risk factors for the development of extensive cystic leukomalacia. Am J Dis Child 1988;142:732-5.
74. Perlman JM, Risser R, Broyles RS. Bilateral cystic periventricular leukomalacia in the premature infant: Associated risk factors. Pediatrics 1996;97:822-7.
75. De Vries L, Wiggelsworth JS, Regev R, et al. Evaluation of periventricular leukomalacia during the neonatal period and infancy: Correlation of imaging and postmortem findings. Early Hum Dev 1988;17:205-19.
76. Paneth N, Rudelli R, Monte W, et al. White matter necrosis in the very low birth weight infants: Neuropathologic and ultrasonographic findings in infants surviving six days or longer. J Pediatr 1990;116:975-84.
77. De Vries LS, Regev R, Dubowitz LMS. Late onset cystic leukomalacia. Arch Dis Child 61-298-299;1986.
78. Armstrong D, Norman MG. Periventricular leukomalacia in neonates: Complications and sequelae. Arch Dis Child 1974;49:367-75.
79. Banker BQ, Larroche JC. Periventricular leukomalacia of infancy: A form of neonatal anoxic encephalopathy. Arch Neurol 1962;7:386-410.
80. De Reuck J, Chatta AS, Richardson Jr EP. Pathogenesis and evolution of periventricular leukomalacia in infancy. Arch Neurol 1972;27:229-36.
81. De Reuck J. The human periventricular arterial blood supply and the anatomy of cerebral infarctions. Eur Neurol 1971;5:321-34.
82. Takashima S, Tanaka K. Development of cerebrovascular architecture and its relationship to periventricular leukomalacia. Arch Neurol 1978;35:11-6.
83. De Reuck J. Cerebral angioarchitecture and perinatal brain lesions in premature and full term infants. Acta Neurol Scand 1984;70:391-5.
84. Rorke LB. Anatomic features of the developing brain implicated to hypoxic-ischemic injury. Brain Pathol 1992;2:211-21.
85. Cavazzutti M, Duffy TE. Regulation of local cerebral blood flow in normal and hypoxic newborn dogs. Ann Neurol 1982;11:247-57.
86. Szymonowicz W, Walker AM, Yu YH, et al. Regional cerebral blood flow after hemorrhagic hypotension in the preterm, near term and term lamb. Pediatr Res 1990;28:361-70.
87. Young RSK, Hernandez MJ, Yagel SK. Selective reduction of blood flow to white matter during hypotension in newborn dogs: A possible mechanism of periventricular leukomalacia. Ann Neurol 1982;12:445-8.
88. Faix RG, Donn SM. Association of septic shock caused by early onset Group B streptococcal sepsis and periventricular leukomalacia in the preterm infant. Pediatrics 1985;76:415-9.
89. Fujimoto S, Togari H, Yamaguchi N, et al. Hypocarbia and cystic periventricular leukomalacia in premature infants. Arch Dis Child 1994;71:F107-10.
90. Griesen G, Munck H, Lou H. Severe hypocarbia in preterm infants and neurodevelopmental deficit. Acta Paediatr Scand 1986;76:401-4.
91. Low JA, Froese AF, Galbraith RS, et al. The association of fetal and newborn acidosis with severe periventricular leukomalacia in the preterm infant. Am J Obstet Gynecol 1990;162:977-82.
92. Perlman JM, Hill A, Volpe JJ. The effect of patent ductus arteriosus on flow velocity in the anterior cerebral arteries: Ductal steal in the premature newborn infant. J Pediatr 1981;99:767-71.
93. Perlman JM, Volpe JJ. Episodes of apnea and bradycardia in the preterm newborn: Impact on cerebral circulation. Pediatrics 1985;76:333-8.
94. Wiswell TE, Graziani LJ, Kornhauser MS. Effects of hypocarbia on the development of cystic periventricular leukomalacia in premature infants treated with high frequency jet ventilation. Pediatrics 1996;98:918-24.
95. Back SA, Volpe JJ. Cellular and molecular pathogenesis of periventricular white matter injury. MRDD Res Rev 1997;3:96-107.
96. Yoon BH, Kim CJ, Romero CJ. Experimentally induced intrauterine infection causes fetal brain white matter lesions in rabbits. Am J Obstet Gynecol 1997;177:797-802.
97. Yue X, Mehmet H, Penrie J, et al. Apoptosis and necrosis in the newborn piglet brain following transient cerebral hypoxia ischemia. Neuropathol Appl Neurobiol 1997;23:16-25.
98. Chamnanvanakij S, Margraf LR, Bums D, et al. Apoptosis and white matter injury in preterm infants. Pediatr Dev Path 2002;5:184-9.
99. Oka A, Belliveau MJ, Rosenberg PA, et al. Vulnerability of oligodendroglia to glutamate pharmacology, mechanisms and prevention. J Neurosci 1993;13:1441-53.
100. Yonezawa M, Back SA, Gan X, et al. Cystine deprivation induces oligodendroglial death. Rescue by free radical scavengers and by a diffusible glial factor. J Neurochem 1996;67: 566-73.
101. Gan XD, Back SA, Rosenberg PA, et al. State-specific vulnerability of rat oligodendrocytes in cuture to non-NMDA receptors mediated toxicity [abstract]. Soc Neurosci 1997;2:17420.
102. Follett PL, Rosenberg RA, Volpe JJ, et al. NBQX attenuates excitotoxic injury in developing white matter. J Neurosci 2000;20:9235-41.
103. Bona E, Anderson E, Blomgrunk K, et al. Chemokines and inflammatory cell response to hypoxia ischemia in immature rats. Pediatric Res 1999;45:500-49.
104. Selmaj K, Raine CS, Farooq M. Cytokine cytotoxicity against oliodendrocytes: Apoptosis induced by lymphotoxin. J Immunol 1991;147:1522-9.
105. Andrews T, Zhang P, Bhat NR. TNFα potentiates IFNy-induced cell death in oligodendrocyte precursor. Neurosci Res 1998;54:574-83.
106. Dommergues MA, Patkai J, Renauld JC, et al. Proinflammatory cytokines and interleukin 9 exacerbate excitotoxic lesions of the newborn murine neopallium. Ann Neurol 2000;4:154-6.
107. Saija A, Princi P, Lanza M, et al. Systemic cytokine administration can affect blood-brain permeability in the rat. Life Sci 1995;56:775-84.
108. Nestlin WF, Gimbrone Jr MA. Neutrophil mediated damage to human vascular endothelium: Role of cytokine activation. Am J Path 1993;142:117-28.
109. Ando M, Takashima S, Mito T. Endotoxin, cerebral blood flow, amino acids and brain damage in young rabbits. Brain Dev 1988;10:365-70.
110. Gilles FH, Leviton A, Kerr CS. Endotoxin leukoencephalopathy in the telencephalon of the newborn kitten. J Neurol Sci 1976;27:183-91.
111. Zusban V, Gonzalez P, Lacaze Masmontiel T, et al. Periventricular leukomalacia: Risk factors revisited. Dev Med Child Neurol 1996;38:1066-70.
112. Leviton A, Pareth N, Reuss L, et al. Maternal infection, fetal inflammatory response and brain damage in very low birth weight infants. Pediatr Res 1999;46:566-75.
113. Baud O, Emilie D, Pelletier E, et al. Amniotic fluid concentrations of interleukin-1 beta, interleukin-6 and TNF-alpha in chorioamnionitis before 32 weeks of gestation: Histological associations and neonatal outcome. Br J Obstet Gynaecol 1999;106:72-7.
114. Hillier SL, Witkin SS, Krohn MA, et al. The relationship of amniotic fluid cytokines and preterm delivery, amniotic fluid infection, histologic chorioamnionitis and chorioamnion infection. Obstet Gynecol 1996;174:330-4.
115. Saito S, Kasahara T, Kato Y, et al. Elevation of amniotic fluid interleukin 6- (IL-6), IL-8, and granulocyte stimulating factor (G-CSF) in term and preterm parturition. Cytokines 1993; 5:81-8.
116. Yoon BH, Jun JK, Romero R, et al. Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia. Am J Obstet Gynecol 1996;174:1433-40.
117. Grether JK, Nelson KD. Maternal infection and cerebral palsy in infants at normal birth weight. JAMA 1997;278:207-11.
118. Grether JK, Nelson KB, Dambrosia JM, et al. Interferons and cerebral palsy. J Pediatr 1999;134:324-32.
119. Wu YW, Colford Jr JM. Chorioamnionitis as a risk factor of cerebral palsy: A meta-analysis [review]. JAMA 2000;284:1417-24.
120. Deguchi K, Mizoguchi M, Takashima S. Immunohistochemical expression of tumor necrosis factor α in neonatal leukomalacia. Pediatr Neurol 1996;14:6-13.
121. Yoon BH, Romero R, Kim CJ, et al. High expression of tumor necrosis factor α and interleukin 6 in periventricular leukomalacia. Am J Obstet Gynecol 1997;177:406-11.
122. Bonce AJ, Boling W, Kindy MS, et al. Altered neuronal and microglial response to excitotoxic and ischemic brain injury in mice lacking TNF receptor. Nat Med 1996;2:788-94.
123. Graziani LJ, Spitzer AR, Mitchell DG, et al. Mechanical ventilation in preterm infants: Neurosonographic and developmental studies. Pediatrics 1992;90:515-22.
124. Trounce JQ, Shaw DE, Levene MI, et al. Clinical risk factors and periventricular leukomalacia. Arch Dis Child 1988;63:17-22.
125. Weindling AM, Wilkinson AR, Cook F, et al. Perinatal events which precede periventricular hemorrhage and leukomalacia in the newborn. Br J Obstet Gynecol 1985;92:1218-23.
126. Mirro R, Buslta D, Green R, et al. Relationship between mean airway pressure, cardiac output and organ blood flow with normal and decreased respiratory compliance. J Pediatr 1987;111: 101-6.
127. Phelps DL, Rosenbaum AL, Isenberg SJ, et al. Tocopherol efficacy and safety for preventing retinopathy of prematurity: A randomized controlled, boule-masked trial. Pediatrics 1987;79: 489-500.
128. Fazzi E, Lanzi G, Gerardo A, et al. Neurodevelopmental outcome in very low birth weight infants with or without periventricular hemorrhage and/or leukomalacia. Acta Paediatr 1992;81:808-11.
129. Roger B, Msall M, Owens T, et al. Cystic periventricular leukomalacia and type of cerebral palsy in preterm infants. J Pediatr 1994;125:51-8.
130. De Vries LS, Connell JA, Dubowitz LMS, et al. Neurological electrophysiological and MRI abnormalities in infants with extensive cystic leukomalacia. Neuropediatrics 1987;18:61-6.
131. De Vries LS, Eken P, Groenendaal F, et al. Correlation between the degree of periventricular leukomalacia using cranial ultrasound and MRI in infancy, in children with cerebral palsy. Neuropediatrics 1993;24:263-8.
132. Jacobson LK, Dutton GN. Periventricular leukomalacia: An important cause of visual and ocular motility dysfunction in children [review]. Survey of Ophthalmology 2000;45:1-13.
133. Melhem ER, Hoon AH, Ferrucci JT, et al. Periventricular leukomalacia: Relationship between lateral ventricular volume on brain MR images and severity of cognitive and motor impairment. Radiology 2000;214:199-204.
134. Scher MS, Dobson V, Carpenter NA, et al. Visual and neurological outcome of infants with periventricular leukomalacia. Dev Med Child Neurol 1989;31:353-65.